These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9368196

  • 1. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
    Seifritz E, Müller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U, Moore P, Holsboer-Trachsler E.
    J Psychiatr Res; 1997; 31(5):543-54. PubMed ID: 9368196
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral racemic citalopram on neuroendocrine responses.
    Hawken ER, Owen JA, Van Vugt D, Delva NJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):694-700. PubMed ID: 16563590
    [Abstract] [Full Text] [Related]

  • 3. Neuroendocrine effects of citalopram infusion in anorexia nervosa.
    Mondelli V, Gianotti L, Picu A, Abbate Daga G, Giordano R, Berardelli R, Pariante CM, Fassino S, Ghigo E, Arvat E.
    Psychoneuroendocrinology; 2006 Nov; 31(10):1139-48. PubMed ID: 17045409
    [Abstract] [Full Text] [Related]

  • 4. Low-dose citalopram as a 5-HT neuroendocrine probe.
    Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ.
    Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS, Attenburrow MJ, Cowen PJ.
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [Abstract] [Full Text] [Related]

  • 6. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
    Henning J, Netter P.
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
    [Abstract] [Full Text] [Related]

  • 7. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
    Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RW.
    Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
    Berardelli R, Margarito E, Ghiggia F, Picu A, Balbo M, Bonelli L, Giordano R, Karamouzis I, Bo M, Ghigo E, Arvat E.
    J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of serotoninergic challenge with oral citalopram.
    Mattos P, Franco VA, Noel F, Segenreich D, Gonçalves JC.
    Braz J Psychiatry; 2006 Sep; 28(3):203-5. PubMed ID: 17063220
    [Abstract] [Full Text] [Related]

  • 10. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER, Owen JA, Hudson RW, Delva NJ.
    Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
    [Abstract] [Full Text] [Related]

  • 11. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
    Lotrich FE, Bies R, Muldoon MF, Manuck SB, Smith GS, Pollock BG.
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
    [Abstract] [Full Text] [Related]

  • 12. Infusion of a lipid emulsion in healthy men decreases the serotonergic response.
    Sondermeijer BM, Klein Twennaar CF, Kastelein JJ, Franssen EJ, Hutten BA, Dallinga-Thie GM, Stroes ES, Fliers E, Twickler MT, Serlie MJ.
    Neuroendocrinology; 2012 Mar; 95(4):325-31. PubMed ID: 22327404
    [Abstract] [Full Text] [Related]

  • 13. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
    Kilkens TO, Honig A, Fekkes D, Brummer RJ.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):865-74. PubMed ID: 16225497
    [Abstract] [Full Text] [Related]

  • 14. Citalopram challenge in social anxiety disorder.
    Shlik J, Maron E, Tru I, Aluoja A, Vasar V.
    Int J Neuropsychopharmacol; 2004 Jun 01; 7(2):177-82. PubMed ID: 14741063
    [Abstract] [Full Text] [Related]

  • 15. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
    Markianos M, Hatzimanolis J, Lykouras L.
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug 01; 252(4):172-6. PubMed ID: 12242578
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The citalopram challenge test in patients with major depression and in healthy controls.
    Kapitany T, Schindl M, Schindler SD, Hesselmann B, Füreder T, Barnas C, Sieghart W, Kasper S.
    Psychiatry Res; 1999 Nov 08; 88(2):75-88. PubMed ID: 10622344
    [Abstract] [Full Text] [Related]

  • 18. State and trait abnormalities in serotonin function in major depression.
    Bhagwagar Z, Whale R, Cowen PJ.
    Br J Psychiatry; 2002 Jan 08; 180():24-8. PubMed ID: 11772847
    [Abstract] [Full Text] [Related]

  • 19. S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants.
    Kuepper Y, Bausch S, Iffland J, Reuter M, Hennig J.
    Psychoneuroendocrinology; 2006 Nov 08; 31(10):1200-7. PubMed ID: 17123742
    [Abstract] [Full Text] [Related]

  • 20. Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis.
    Muldoon MF, Mackey RH, Sutton-Tyrrell K, Flory JD, Pollock BG, Manuck SB.
    Stroke; 2007 Aug 08; 38(8):2228-33. PubMed ID: 17626900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.